Home >> Chemicals Listing >> hot product list by C  

Cyclohexanecarboxylicacid, 4-[3-[6-amino-9-(N-ethyl-b-D-ribofuranuronamidosyl)-9H-purin-2-yl]-2-propyn-1-yl]-, methyl ester,trans- (250386-15-3)

Identification
Name:Cyclohexanecarboxylicacid, 4-[3-[6-amino-9-(N-ethyl-b-D-ribofuranuronamidosyl)-9H-purin-2-yl]-2-propyn-1-yl]-, methyl ester,trans-
Synonyms:Cyclohexanecarboxylicacid, 4-[3-[6-amino-9-(N-ethyl-b-D-ribofuranuronamidosyl)-9H-purin-2-yl]-2-propynyl]-, methyl ester,trans- (9CI); ATL 146e; Apadenoson; BMS 068645; DWH 146e
CAS:250386-15-3
Molecular Formula: C23H30 N6 O6
Molecular Weight: 0
InChI: InChI=1/C23H30N6O6/c1-3-25-21(32)18-16(30)17(31)22(35-18)29-11-26-15-19(24)27-14(28-20(15)29)6-4-5-12-7-9-13(10-8-12)23(33)34-2/h11-13,16-18,22,30-31H,3,5,7-10H2,1-2H3,(H,25,32)(H2,24,27,28)/t12?,13?,16?,17?,18-,22+/m0/s1
Molecular Structure: (C23H30N6O6) Cyclohexanecarboxylicacid, 4-[3-[6-amino-9-(N-ethyl-b-D-ribofuranuronamidosyl)-9H-purin-2-yl]-2-prop...
Properties
Flash Point: °C
Boiling Point: °Cat760mmHg
Density:1.54g/cm3
Refractive index:1.703
Flash Point: °C
Usage:An A2A adenosine receptor agonist. Adjunct to nuclear myocardial perfusion imaging in patients unable to exercise adequately
Safety Data
 

Other Product